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Abstract 
Biological studies on in vitro cell cultures are of fundamental importance to investigate cells response to external 
stimuli, such as new drugs for treatment of specific pathologies, or to study communication between electrogenic 
cells. Although three-dimensional (3D) nanostructures brought tremendous improvements on biosensors used for 
various biological in vitro studies, including drug delivery and electrical recording, there is still a lack of 
multifunctional capabilities that could help gaining deeper insights in several bio-related research fields. In this 
work, the electrical recording of large cell ensembles and the intracellular delivery of few selected cells are 
combined on the same device by integrating microfluidics channels on the bottom of a multi-electrode array 
decorated with 3D hollow nanostructures. The novel platform allows to record intracellular-like action potentials 
from large ensembles of cardiomyocytes derived from human Induced Pluripotent Stem Cells (hiPSC) and from 
the HL-1 line, while different molecules are selectively delivered into single/few targeted cells. The proposed 
approach shows high potential for enabling new comprehensive studies that can relate drug effects to network 
level cell communication processes.  
 
 
Introduction 
Intracellular delivery is a fundamental method to study diseases and to investigate biological processes that affect 
cell functioning and communication with the extracellular environment. Plasmids, nanoparticles, fluorescent dyes 
or any bio-molecule need to be injected into cells to study their effects on physiology1. However, their introduction 
in the intracellular compartment is often challenging due to the cellular membrane that acts as barrier. Cytosolic 
delivery relies on established methods to transfer reagents across the cell membrane, such as viral vectors2 for 
single-cell gene transfection and endocytosis of specific carriers (lipofectamine, cationic polymers). However, 
these methods are often hampered by lack of specificity, low efficiency, high expenses and even toxicity to the 
cell itself, as well as for specifically inhibiting signal transduction pathways that often involve small peptide 
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inhibitors of protein kinases that are not cell-permeant. These drawbacks have led to the development of more 
direct approaches to physically breach the cell membrane, among which micropipetting and electroporation are 
the most common3,4. Furthermore, recent advances in nanofabrication techniques, together with a deepened 
understanding of the cell-substrate interaction5,6, have enabled the realization of nanostructured platforms for 
improved intracellular delivery7,8, providing selectivity, lower invasiveness and better localization of the delivery 
process. As we have recently shown, using high aspect ratio 3D hollow gold nanoelectrodes in combination with 
electroporation or optoporation, it is possible to open transient nanopores into the cell membrane with controlled 
spatial localization and without compromising the cell/nanoelectrode coupling, allowing for intracellular delivery 
controlled in space and time9,10. 
For the investigation of neurons and cardiomyocytes, which are among the most important cells in regard to drug 
development and cell biology, the monitoring of their electrical activity is fundamental for their proper 
characterization, especially in large cultures where collective behavior can influence the functioning of single 
cells11. Consequently, biological experiments in which molecules or drugs are delivered to these cells should be 
implemented also in their recording capabilities to gain comprehensive insights into the delivery effects. However, 
the fabrication complexity of nano-fluidic nanostructures prevented so far the realization of devices that could 
integrate intracellular delivery and electrical recording on the same platform. In fact, with biosensors for electrical 
recording of electrogenic cell cultures, such as multi-electrode arrays (MEAs) and CMOS-MEAs12–14, the common 
drug delivery methods are mostly performed on entire cellular networks, which are globally affected by the 
treatment under investigation. Deeper and more crucial understandings could be gained by investigating the firing 
activity of large cell populations in which only single or few identified cells have been addressed by intracellular 
delivery. For example, pathologies may be induced to only few cells in order to study the reaction of the whole 
culture, simulating thus the early stage development of several diseases, or alternatively, drugs may be 
administered on partial regions of a cell culture to evaluate the electrical response in the case of inhomogeneous 
drug distribution15. In the case of cardiomyocytes, the signal propagation over the culture could reveal unexpected 
behaviors of the syncytia between delivered and unaffected cells. In recent years, several approaches have been 
presented to implement microfluidics on MEA through PDMS (Polydimethylsiloxane) or polymer channels placed 
onto the surface of the arrays16–18. These strategies provided ways, for example, to configure different culture 
conformations by confining cell growth into compartments. However, they do not reach the spatial resolution 
required to address single cells for drug delivery nor do they provide a nanoscale interface for intracellular access. 
In an attempt to fill this technological gap, here we present a novel multifunctional MEA biosensor that combines 
network level electrical recording with single cell intracellular delivery, realizing a complete and ready-to-use 
platform for extra-/intracellular recordings of electrogenic cells (cardiomyocytes) and simultaneous molecule 
delivery in a non-invasive and selective way (figure 1a). The proposed system consists of a MEA design fabricated 
on a very thin silicon nitride membrane and decorated with three-dimensional (3D) hollow nanostructures. In this 
configuration, the MEA layout allows recording of large ensembles of cells and addressing of few to single cells 
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with high spatio-temporal control, whereas the hollow nanostructures enable controlled delivery of reagents in 
specific locations of the cell culture.  
 
 
Results and discussion 
 
The biosensor concept 
The novel platform is built on the well-established concept of the passive MEA device, which consists of a matrix 
of planar gold electrodes and represents the gold standard for the electrical characterization of large cell networks. 
In our approach, the typical elements of the MEA structure (electrodes, feed lines, passivation) are fabricated on 
a thin silicon nitride layer (500 nm) deposited on a silicon wafer (see a representative sketch in figure 1a and the 
MEA photograph in figure 2c). On the backside of the MEA we selectively remove the silicon beneath the Si3N4 
layer, forming two or more thin nitride membranes (see figure 2d, f and figure S3) that run underneath the gold 
electrodes and act as microfluidic channels (micro-channels). Each MEA electrode is decorated with 3D gold 
nanotubes that are through-hole (see figure 2e, g), thus connecting the two sides of the thin nitride membrane. In 
essence, exploiting the favourable geometric characteristics of 3D hollow metallic nanopillars, we can take 
advantage of electroporation to get direct access to the cell interior with high spatial localization and perform 
multiple functionalities at the same time. On the one hand, they act as nano-fluidic channels for the flow of 
molecules or drugs from the underlying channels, providing a way to deliver them locally only to the cells lying 
on the nanotubes. On the other hand, the gold nanotubes are connected to the planar MEA electrode and offer 
electrical recording with major improvements over signal quality and spatio-temporal resolution for the recording 
of large population of cells19,20, increasing the cell-electrode seal resistance and thus reducing parasitic signal 
losses. 
For our experiments, we used a MEA array of 24 electrodes placed in a 4×6 matrix and with an inter-electrode 
pitch of 400 µm, resulting in an active area of 2×1.2 mm2. Beneath the active area, we fabricated different 
microfluidic configurations with 2, 4 and 6 independent channels (see figure 1b-d), each interfacing several 
electrodes decorated with 3D hollow nanoelectrodes (figure 2g). These microfluidic configurations could be 
fabricated with the same techniques, with no adjustment required for the fabrication of the samples presenting the 
higher number of channels. In order to reduce the complexity of the tubing during electrophysiological 
experiments, we accumulated statistics using the devices with two microfluidic channels for cell culture, electrical 
recording and fluorescence imaging. 
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Figure 1. The biosensor concept. a) Cross-sectional sketch of the MF-MEA biosensor enabling multiple 
functionalities at the same time. b)-d) Optical images of various microfluidic configurations with, respectively, 2, 
4 and 6 independent micro-channels. The different colours of the substrate refer to the silicon nitride membranes 
(brighter) and bulk silicon frame (darker). The scale bars are 500 μm. 
 
Electrophysiological recording of cardiomyocyte spontaneous beating and electroporation 
The microfluidic-MEAs (MF-MEAs) were packaged using a custom-designed PCB board (figure 2a) that allows 
for the tubing access from underneath (figure 2b). Even with the integrated multiple capabilities, the proposed 
platform remains still compatible with standard MEA acquisition systems such as those from Multichannel 
Systems GmbH. 
Extracellular and intracellular-like recordings were performed on cardiomyocytes derived from human Induced 
Pluripotent Stem Cells (hiPSC) and on HL-1 cells derived from rat cardiomyocytes, using our nanostructured 
electrodes both as sensing elements and for electroporation. The hiPSC derived cardiomyocytes represent a 
promising future benchmark for drug screening experiments on cardiac cells and are being investigated 
comprehensively by the scientific community21–23. On the other hand, the cells of the HL-1 line, having been 
characterized extensively in literature20,24,25, represent a well-established experimental bench to test the recording 
performance of newly designed MEAs. Experiments were executed outside the incubator keeping the temperature 
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at 37 °C by means of a Peltier cell attached to a properly designed aluminum cage surrounding the culture well. In 
order to maintain sterility without affecting CO2 exchange, a PDMS thin membrane was attached onto the glass 
ring prior to experiments. The compact MEA biosensor was then mounted on a custom-designed amplifier (MEA 
acquisition system) acquiring data from 24 electrodes at a 10 kHz sampling rate. Electrical recordings with the 
MF-MEAs were obtained in 6 cultures and with 10 different devices (4 cultures and 6 devices with HL-1 cells; 2 
cultures and 4 devices with hiPSC cardiomyocytes). The recordings were performed after approximately 4-5 days-
in-vitro (DIV) to let the culture reach confluence, which is necessary to obtain a spontaneous synchronized firing. 
Figure 2h shows examples of hiPSC human cardiomyocyte spontaneous electrophysiological activity from one of 
the 24 channels of a MF-MEA at 4 DIV. The signal-to-noise ratio (SNR) of the extracellular spikes is considerably 
high, allowing for the full characterization of the cardiomyocyte culture in terms of beating frequency and 
propagation patters. Hence, the presence of the microfluidic channels below the device does not degrade the 
electrical recording performance of the MF-MEAs. To achieve intracellular recording, we use a soft 
electroporation protocol that exploits the 3D nature of the hollow nanoelectrodes to porate the cellular membrane10. 
A train of voltage pulses (consisting of 200 consecutive symmetric square pulses, each with a 50 ms period, a 100 
µs duration and 2.5 V amplitude) were applied through single nanostructured electrodes, without affecting the rest 
of the cell culture. Recordings were resumed less than 30 s after electroporation and showed (see figure 2i) a clear 
change of both spike duration and waveform, together with polarity inversion that is typical of intracellular-like 
signals. Most importantly, the duration of the spike increases from few milliseconds to more than 50 ms after the 
switch to the intracellular-like configuration (figure S4), allowing for the proper characterization of drugs on 
cardiac cells. In fact, the effects of many drugs on the heart are mainly determined by changes of depolarizing and 
repolarizing currents, which are quantified by the spike duration at different amplitude levels. Interestingly, the 
post-electroporation signals maintained intracellular characteristics over several minutes with a slow reduction in 
amplitude over time, presumably due to resealing of transient membrane pores. The spontaneous activity resumes 
extracellular features after 10 – 15 minutes as already observed in literature for similar cells after electroporation20. 
In supporting information we report additional electrical measurements performed on hiPSC cardiomyocytes 
(figure S4) and HL-1 cells (figure S5).  
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Figure 2. MEA device and electrical recordings. a)-b) Respectively top and bottom view of the packaged MF-
MEA. The scale bar is 0.5 mm. c)-d) Top and bottom view showing, respectively, the MEA, feedlines and contact 
pads and the independent microfluidic channels underneath. e) Scanning Electron Microscopy (SEM) image of a 
MEA electrode decorated with gold-coated hollow nanostructures and surrounded by a SU-8 passivation layer. 
The scale bar is 5 m. f) SEM image of the microfluidic channels selectively etched underneath the active area of 
the MF-MEA. The MEA electrodes at the other side are visible through the thin silicon nitride membranes. The 
scale bar is 500 m. g) SEM image of a Focused Ion Beam (FIB) cross-sectioned nanoelectrode connecting the 
microfluidic compartment with the culture well. The scale bar is 500 nm. h) Spontaneous electrophysiological 
spiking activity of hiPSC cardiomyocytes from one of the 24 channels of a MF-MEA at 4 DIVs and detail of three 
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consecutive spikes. i) Intracellular-like activity of hiPSC cardiomyocytes acquired on the same electrode after 
electroporation and detail of three consecutive spikes. 
 
Intracellular delivery 
In order to test the effectiveness of our multifunctional platform, we performed selective delivery of molecules 
through the 3D nanoelectrodes during the recording sessions. The hollow nanoelectrode design enables to address 
only few selected cells, without affecting the electrical activity of the whole network. As a first proof-of-concept 
of our technology, calcein-AM, a membrane permeant molecule producing a green fluorescence at λ=515 nm, was 
delivered at a concentration of 200 M in a Phosphate Buffer Solution (PBS) 1X to the cells (electroporated or 
not) interfacing the 3D nanoelectrodes on the Si3N4 membrane. The desired solution was previously incubated at 
37 °C, and was then injected with our pumping system into the two isolated microchannels, allowing the 
fluorophores to diffuse through the nanoelectrode just in small portions of the biosensor surface. Figure 3a shows 
the green fluorescence image acquired with an optical microscope (air objective 5×) while the whole cell culture 
was live and electrically active. The fluorescence image were taken 1 hour after the addition of calcein-AM in the 
microfluidic channels below the MEA. This time was needed to allow the calcein-AM to diffuse into the 3D hollow 
nanoelectrodes and to access the cellular membrane. Before imaging, the calcein-AM solution was then substituted 
by PBS in order to rinse both the tubing and the microchannels, removing calcein-AM residuals. As it can be seen, 
calcein-AM is selectively delivered only to the cells that are tightly sealed on top of the nanostructured electrodes. 
The delivery selectivity reaches almost 100% thanks to the tight cell adhesion on the hollow nanopillars, which 
prevents the diffusion of the dye molecule into the rest of the cell culture.  
In other experiments, we injected into the microfluidic channels a saline solution with Propidium Iodide (PrhD-
1), a non-permeant molecule which binds nucleic acids and emits a bright red fluorescence at λ=635 nm, with a 
concentration of 1 mM in PBS 1X. Electroporation pulses were applied through the 3D nanoelectrodes of the MEA 
electrodes interfacing the microfluidic channels in order to open transient pores in the cellular membrane and to 
deliver the PrhD-1 inside the cells. As it can be seen in figure 3b and 3c, PrhD-1 is delivered only to the 
cardiomyocytes laying on the electrodes and hence subjected to electroporation, thus providing a clear evidence 
of the high selectivity and spatial control achieved by our multifunctional platform. We also investigated the 
possibility to deliver non-permeant and permeant molecules through the same microfluidic channels. Figure 3d, 
e, f shows bright-field and fluorescence images of four MEA electrodes (A, B, C and D) after we delivered both 
calcein-AM and PrhD-1 and applied selective electroporation only to electrodes B and D. We observe the selective 
delivery of calcein-AM on the cells laying on the four electrodes (figure 3e), whereas we note that PrhD-1 is 
delivered only to the electroporated cells laying on the electrodes B and D (figure 3f). The fluorescence images 
were acquired simultaneously with the electrical recording of the same cells, which indeed showed polarity 
inversion of the recorded signals due to the intracellular action potential contribution (insets in figure 3e, f). The 
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same experiments were performed on different sets of electrodes, finding good results in terms of reproducibility 
and intracellular selectivity (see figure S6). The cells were fixated after recording and delivery in order to acquire 
high resolution images of fluorescence emission with a confocal microscope. Figure 3g shows the detail of one 
electrode on which we have delivered calcein-AM and PrhD-1 and applied electroporation. We can observe the 
red staining of the nuclei due to PrhD-1 and the surrounding green fluorescence due to the calcein-AM staining 
the cell cytoskeleton.  
Further, we studied the effects of culturing the cells over a heterogeneous sample consisting of areas on bulky 
silicon and other regions on thin nitride membrane with PBS underneath, so as to evaluate possible divergences in 
cell proliferation. HL-1 cells were cultured on the microfluidic MEAs and stained with DAPI, a blue staining of 
the nuclei, after 4 DIV. In this case, the staining with DAPI was performed on the complete culture from the glass 
culture well, rather than selectively from the microfluidic channels. The images reveal a homogeneous cell growth 
over the whole MEA surface, with no distinction between the free-standing nitride membranes and the bulk silicon 
part (figure 3h). This ensures that the particular employed device configuration does not influence the cell culture 
growth and development. Moreover, the cell density estimate reported in figure S7 yields similar values on 
different areas (bulk silicon or nitride membranes) of the same device. Figure 3i shows a detail of four electrodes 
after delivery of calcein-AM through the 3D nanoelectrodes and staining with DAPI from the cell culture well. 
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Figure 3. Selective intracellular drug delivery on MF-MEA. a) Fluorescence image of intracellular delivery of 
calcein-AM on all the MEA nanostructured electrodes. The scale bar is 500 m. b) Fluorescence image of 
intracellular delivery of PrhD-1 into selectively electroporated cardiomyocytes. The scale bar is 300 m. c) 
Fluorescence image of intracellular delivery of PrhD-1 into electroporated cardiomyocytes onto four membrane 
electrodes. The scale bar is 100 m. d) Bright-field optical image of four electrodes of a MF-MEA. The scale bar 
is 200 m. e) The same 4 electrodes observed with a green fluorescence filter, showing calcein-AM delivery to 
the cells onto the 4 electrodes. The scale bar is 200 m. f) The same four electrodes observed with a red 
fluorescence filter, showing PrhD-1 delivery to the cells onto the 2 electrodes where electroporation was 
performed. The scale bar is 200 m. g) Confocal image of a nanostructured electrode where both calcein-AM and, 
after electroporation, PrhD-1 have been delivered to the attached cells. The scale bar is 10 m. h) Fluorescence 
image of cardiomyocytes cultured on MF-MEA and stained with DAPI after 4 DIV. The scale bar is 200 m. i) 
Fluorescence image of four electrodes after delivery of calcein-AM through the 3D nanoelectrodes and staining 
with DAPI from the cell culture well. The scale bar is 100 μm.  
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Experimental 
 
Fabrication of nitride membrane and independent microfluidic channels  
In order to obtain a compact and flow-through design, nanostructured MEAs were realized on thin silicon nitride 
(Si3N4) membranes. Membranes and micro-channels were fabricated on a 525 µm thick p-doped (100) Si wafer 
with 500 nm of LPCVD super low stress Si3N4 on both sides (see figure S1 for fabrication protocol). A 400 nm 
thick mask layer of Cr was sputter coated on one of the two wafer sides and a thin layer (≈ 2 µm thick) of a 
common photoresist (MICROPOSIT S1813) was spin-coated on top. Conventional optical UV lithography (SÜSS 
MicroTec Mask Aligner) was employed to expose the desired areas (see figure S1).  After exposure and 60 seconds 
development in (MICROPOSIT MF-319 DEVELOPER), Cr was removed by chemical wet etching in a ceric 
ammonium nitrate-based mixture (Sigma-Aldrich). The remaining unexposed resist was then dissolved in acetone, 
leaving Cr as an etch mask for the Reactive Ion Etching (RIE, SENTECH) process on the Si3N4 underneath. A 
mixture of gases, CHF3 and O2 (at 70 and 10 SCCM respectively, where SCCM is the standard cubic centimeter 
per minute) were used to selectively etch the 500 nm thick Si3N4; the process parameters of pressure, temperature 
and power were held at 1 Pa, 20 °C and 30 W respectively. As a last step, the Cr mask was chemically removed 
and Si was wet etched in a solution of 30% wt. potassium hydroxide (KOH) in deionized water (DI). Given the 
zero etch-rate of Si3N4 under KOH exposure, the wet etching process stops when the nitride is reached at the other 
side of the wafer in correspondence with the membrane apertures, while in the micro-channels stops at the meeting 
point between the etching planes; the final depth of the channels can be varied accordingly to the geometrical 
parameters of the etching area. The present microfluidic design can be easily rescaled from 2 to 6 independent 
channels configurations (see figure 1b-d and figure S3), therefore allowing multiplex applications on the same 
platform. 
 
Microfluidic-MEA 
MEAs decorated with 3D nano-electrodes were fabricated using the technologies developed in other works (Dipalo 
M. et al., Nanoscale 2015, De Angelis F. et al., Nano Letters 2013). Briefly, a thin layer (≈ 2 µm thick) of S1813 
was spin-coated on the Si3N4 membrane (see figure S2 for fabrication protocol). After UV exposure and 60 seconds 
development in MF-319, 24 Ti/Au electrodes, conductive tracks and contact pads were fabricated through electron 
beam evaporation in a high vacuum chamber (base pressure 10-7 mbar) with a 0.3 Å/s deposition rate. The 
unexposed resist and the metal on top of it were removed through a conventional lift-off process in hot Remover 
PG (MicroChem). The substrate was then rinsed out in isopropanol (IPA) and dried with nitrogen. O2 plasma 
ashing at 100 W for 5 minutes was used to remove residual S1813 resist and other organic residues. 24 electrode 
contacts of varying dimensions (from 100 to 900 µm2) were defined by a passivation of SU-8 that covered the rest 
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of the device (see figure 2e). Gold coated 3D nanoelectrodes (figure 2e) were fabricated on the planar electrodes 
by focused-ion-beam (FIB) lithography (setting the exposure dose to 27 nC/µm2)26 from the backside of the Si3N4 
membrane. The obtained hollow nanotubes are characterized by a conical shape (figure 2g), with external diameter 
of about 600 nm and height of 1.3 µm. Due to the fabrication protocol, gold nanoelectrode arrays are realized only 
on those electrodes lying on the nitride membranes, with their number depending on the desired microfluidic 
configuration. In the following, we will only consider the case of two isolated membranes with 8 nanostructured 
electrodes each. The remaining 8 planar electrodes will be used as controls. 
 
MEA packaging 
The complete MEA with nanostructured electrodes was then mounted on a PCB (printed-circuit-board) and 
passivated with Polydimethylsiloxane (PDMS) that covers the electrical connections with the PCB. Due to its 
chemical characteristics, PDMS ensures non-toxicity, inertness and biocompatibility. A glass ring was attached on 
the MEA by means of PDMS to form a culture well (see figure 2a). After this, the open micro-channels on the 
bottom side of the MEA were sealed with a piece of polymerized PDMS. Tight bonding between the Si3N4 and 
the PDMS was ensured by chemical activation of both surfaces via an oxygen plasma treatment for 30 s at a 
pressure of 0.5 mbar, 25 SCCM of oxygen and 30 W power. In order to improve the bonding stability and 
efficiency, the sample was then baked in a hoven at 80 °C for 30 minutes. The PDMS bonding step assures the 
realization of two non-communicating chambers with independent inlet and outlet, thus enabling the selective 
delivery of reagents in different areas of the MEA. As a last step, using biopsy punches holes were drilled through 
the PDMS piece (in correspondence with the micro-channels underneath) and tubing was added to provide external 
connections with our pumping system (see figure 2b). 
 
Pumping system 
A commercial pressure-driven microfluidic flow control system (MFCS-EZ, FLUIGENT) was employed to 
selectively deliver different solutions in the microfluidic chambers underneath the nitride membranes. By 
connecting the system pressure outputs to airtight reservoirs, containing the desired reagents, we were able to 
precisely control the liquid flow into the microfluidic device. The flow-rate was adjusted to 100 μL/min to ensure 
flow stability and smoothness. 
 
Culture of HL-1 cardiomyocytes 
The MF-MEAs have been sterilized with 20 minutes-UV exposure in laminar flow hood and incubated overnight 
(o.n.) with Claycomb culture medium in order to saturate the PDMS porous matrix of the culture well. 
Furthermore, the micro-channels and tubing at the bottom of the device have been manually filled with Claycomb 
using a sterile syringe. The day after, the medium has been completely removed from the culture well and the 
substrates have been treated with poly-L-lysine 0,01% w/v (Sigma-Aldrich) for five minutes, washed extensively 
   
 
12 
 
with water and let dry in sterile condition. Subsequently, HL1 cells have been seeded at the density of 35000/cm2 
and grown with Claycomb, supplemented with 10% fetal bovine serum, 100 µM norepinephrine, 300 µM ascorbic 
acid, 2 mM L-glutamine, penicillin and streptomycin (Sigma-Aldrich). The culture medium has been changed 
daily. When 100% confluence was reached, the electrical activity of cells has been recorded. 
 
Human induced Pluripotent Stem Cells-derived cardiomyocytes 
HiPSCs (Axiogenesis) have been thawed and pre-cultured in a cell culture flask and growth o.n. in Cor.4U 
complete medium (Axiogenesis) before seeding on samples. This procedure allows removal of dead cells prior to 
seeding and will result in better assay performance. The MF-MEAs have been sterilized with 20 minutes-UV 
exposure in laminar flow hood and incubated o.n. with Cor.4U complete medium in order to saturate the PDMS 
passivation of the electrical connections. After the incubation, samples were treated in order to promote the tight 
adhesion of cells. The substrates were coated with Geltrex ready-to-use solution (Thermo Fischer Scientific) and 
then incubated for 30 minutes at 37°C in a humidified environment. As a following step, the solution was totally 
removed and cells were rapidly plated without the coating was allowed to dry. HiPSCs-derived cardiomyocytes 
have been plated at the density of 70000/ cm2 and grown with Cor.4U complete medium. 
 
Cell fixation 
Samples were fixed with PFA 4% in PBS. After a 30 minutes incubation at room temperature, samples have been 
extensively washed with PBS and treated with Triton 0.1% in PBS and stained with DAPI (Invitrogen) in order to 
mark the nuclear compartment of cells. 
 
Fluorescence imaging and confocal microscopy 
Confocal imaging of HL-1 cardiomyocytes was performed with a Leica TCS SP5 AOBS Tandem DM6000 upright 
microscope equipped with a 25× objective (Leica IRAPO, NA = 0.95). Data were subsequently analyzed by LASX 
V2.0 software (Leica Microsystems). Fluorescence imaging during electrical recording was performed with a 
Nikon FN-1 microscope using 5× and 20× air objectives and a 60× water-immersion objective. 
 
 
Conclusion 
In this work, we presented a novel multifunctional biosensing platform with high level integration of microfluidics 
and recording capabilities. The approach combines various bio-nanotechnologies to perform selective intracellular 
delivery of molecules, extracellular action potential recording and intracellular recording by means of 
electroporation. We successfully performed intracellular recording of human iPSC derived cardiomyocytes and 
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intracellular delivery of two different molecules in few selected cells, while the electrical activity of the whole 
cultures was monitored. 
The peculiar properties of the 3D gold hollow nanostructures and of the multiple microfluidic channels will allow 
to inject molecules into selected cells and to measure the consequent response of the whole cell network. Moreover, 
different molecules may be injected in various and specific parts of the cell culture through independent 
microfluidic channels, so that the electrical response of the cell culture can be observed also in the presence of 
multiple drugs or molecules. The platform may provide new methodologies to study early stage pathologies and 
to evaluate toxicity of drugs, molecules and nanoparticles. In perspective, the same configuration may be used in 
the future also for performing intracellular sampling as already suggested by Y. Cao et al.27, combining 
intracellular sampling and electrical recording of the same cells in a large network. 
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Figure S1. Schematic representation of membranes and micro-channels fabrication protocol. 
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Figure S2. Schematic representation of the microfluidic MEA fabrication protocol. 
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Figure S3. Different microfluidic arrangements. a)-c) Optical images of different microfluidic configuration, 
respectively with 3, 4 and 6 micro-channels, acquired from the recording side of the device. The scale bar is 500 
m. d)-f) Optical images of different microfluidic configuration, respectively with 3, 4 and 6 micro-channels, 
acquired from the delivery side of the device. The scale bar is 2.5 mm. 
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Figure S4. Long recording on hiPSC cardiomyocytes. After electroporation, the spontaneous electrophysiological 
spiking activity is modified into intracellular-like spikes. The spontaneous activity resumes extracellular features 
after 10 – 15 minutes upon resealing of the transient membrane pores. 
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Figure S5. Extra and intra-cellular recording on HL-1 cardiomyocytes. a)-b) Spontaneous electrophysiological 
spiking activity of HL-1 cardiomyocytes from one of the 24 channels of a MF-MEA. c)-d) Intracellular-like 
activity of HL-1 cardiomyocytes acquired on the same electrode after electroporation. 
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Figure S6. Selective intracellular drug delivery on MF-MEA. a) Bright-field optical image of four electrodes of a 
MF-MEA. The scale bar is 200 m. b) The same 4 electrodes observed with a green fluorescence filter, showing 
calcein-AM delivery to the cells onto the 4 electrodes. The scale bar is 200 m. c) The same four electrodes 
observed with a red fluorescence filter, showing PrhD-1 delivery to the cells onto the 2 electrodes where 
electroporation was performed. The scale bar is 200 m. 
 
 
 
 
 
 
 
 
Figure S7. Cell density estimate after 4 DIV. a) Fluorescence image of cardiomyocytes cultured on MF-MEA and 
stained with DAPI after 4 DIV. The red-bordered area delimits the nitride membrane. The scale bar is 300 m. b) 
Fluorescence image, acquired on the other membrane region of the same device, of cardiomyocytes cultured on 
MF-MEA and stained with DAPI after 4 DIV. The red-bordered area delimits the nitride membrane. The scale bar 
is 300 m. c) Box plot featuring the cell density distribution calculated for different areas (bulk silicon or nitride 
membranes) on the same device. 
 
